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ABSTRACT
The number of primary and revision knee arthroplasty procedures performed yearly is steadily
increasing. The management of bone loss at the time of revision surgery will play an integral role
in the longevity and function of these knees into the future. There are a variety of options for
addressing these defects varying from the use of polymethylmethacrylate bone cement, metal
augments, sleeves, cones and large allograft replacements. This manuscript discusses the
evaluation, classification and management of bone loss of the distal femur and proximal tibia.
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INTRODUCTION
Total knee arthroplasty (TKA) is one of the most successful adult surgical procedures performed
in orthopedics today. The surgery has an acceptable complication rate and impressive clinical track
records with high patient satisfaction 1, 2. An increasing number of arthroplasty procedures are performed
in younger more active patients, with a proportional increase in the number and demand for revision
surgery in the future. The revision burden is estimated to currently represent around 8% of total knee
replacements and the demand for revision knee replacement is expected to grow by nearly 600% between
2005 and 2030 3, 4. Currently, the most frequent indication for total knee revision is periprosthetic joint
infection, followed by mechanical loosening and then implant failure 5. These technically demanding
procedures can result in large amounts of bone loss during surgery, particularly while removing well fixed
implants or following staged revision with a cement spacer 6.
The surgeon’s ability to address and deal with bony defects during surgery will have a direct
impact on implant longevity and future revision surgeries. This chapter will deal with the fundamentals
and strategies for addressing bone loss about the knee in the revision setting. The keys to successful

outcome include appropriate pre-operative planning, minimizing bone loss during implant removal,
restoration of the joint line and appropriate selection of bone augments and implants.

PREOPERATIVE EVALUATION
A thorough review of the patient’s previous surgery or surgeries, including evaluation of
the operative report and the time between implantation and failure, is crucial. Early onset of
symptoms following surgery may represent mechanical issues related to alignment, rotation or
possible infection. Any wound issues following the index surgery including prolonged drainage,
need for antibiotic therapy or return to the operating room for manipulation or debridement
should be noted. Revision implants with metaphyseal sleeves or trabecular metal cones may
present particular difficulties during removal and greater degrees of bone loss should be
anticipated.
Physical examination should include careful inspection of previous incisions, knee range
of motion and stability as well as a neurovascular examination. Previous incisions should be
noted and a plastic surgery consult is warranted for complex incisions, at risk skin bridges or if a
previous soft tissue flap must be mobilized. Evaluation for venous stasis or arterial issues may
warrant vascular consultation, particularly if pulses are not palpable on examination.
Preoperative imaging should include full length films from hip to ankle to evaluate
alignment, dedicated anterior-posterior and lateral views of the knee, as well as sunrise and notch
views. Expected bone loss is routinely underestimated, particularly on the lateral view of a
posterior stabilized femoral component with a box

7, 8

. Further quantification of rotational

abnormalities and bone loss may be improved with computed tomography of the knee 9.
Templating should be performed preoperatively using the planned implants and
augments. This can also alert the surgeon to the need for large or structural grafts which can be

ordered preoperatively. Stemmed implants are often required for revision cases and the canal
width should be measured preoperatively.
Routine labs include a CRP, ESR to screen for infection and should also be obtained in
all patients. Further workup for infection should performed if these values are elevated 10

CLASSIFICATION
Several classification systems have been developed to assess bone loss in revision TKA.
The most widely used one remains the Anderson Orthopeadic Research Institute (AORI)
classification 11. Bone defects are first classified based on preoperative x-rays and then adjusted
based on intraoperative findings. The femur and tibia are each classified separately into one of
three types (Table1). Type 1 defects include intact metaphyseal bone with no compromise of
implant stability. Type 2 defects involve bone loss in the metaphysis and are further subdivided
based on whether one (type A) or both (type B) condyles are involved. In type 3 defects, a major
portion of the condyle or plateau is affected, often compromising the origin or insertion of the
collateral ligaments.
The Anderson classification may also assist the surgeon in implant selection. Type 1
defects are contained and may be addressed with simple cancellous bone grafting and primary
components. Type 2 defects may require cement augmentation, metal augments or bone grafting
to restore the joint-line. Type 3 defects may require structural bone grafting, metaphyseal
sleeves or trabecular metal cones. Engh et al. have also identified specific radiographic
landmarks that help classify bone loss by assessing their relationship to the implants 11. The
femoral epicondyles, posterior femoral condyles and location of the patella relative to the joint

line are used for the assessment of femoral bone loss. The fibular head and tibial tubercle are
used for the assessment of tibial defects.
Other classification systems have also been described, such as the Toronto classification
by Clatworthy and Gross, which classifies bone defects as contained and uncontained 12, and the
University of Pennsylvania classification system, which is a quantitative classification system 13.

[Insert Table 1 here]

SURGICAL MANAGEMENT
Surgical Exposure should incorporate old incisions and the most lateral incision should
be used when possible to avoid skin necrosis. Short horizontal incisions may be crossed at right
angles and dissection should proceed with elevation of full thickness flaps including skin and
subcutaneous fascia

14

. A medial peri-patellar arthrotomy is preferred with care taken to avoid

injury to the extensor mechanism.
Extraction of components is a crucial step in avoiding unnecessary bone loss. Specialized
instruments should be available including thin flexible osteotomes, micro-blades and extraction
tools for the femur and tibia. A burr and reverse curettes may be used for cement removal. Great
care should be taken to avoid unnecessary perforation of the cortex. Minimal bone cuts are made
about the femur, tibia and patella to remove fiborous tissue. The focus at this stage is on
preserving the maximal amount of viable host bone and determining what may be necessary to
reconstruct deficits.

Addressing bone loss of the patella can be particularly challenging, especially in smaller
patients with little residual bone stock. If the measured residual thickness is less than 11mm then
further resurfacing options are limited secondary to risk of fracture and extensor mechanism
disruption. Alternatives include trabecular metal augments or bone grafting techniques 15-17.
The true joint line should be established early to determine the amount of bone loss of the
proximal tibia and distal femur. There are several reliable landmarks including the residual
meniscal scar, one finger breadth (10-12mm) below the inferior pole of the patella, 3cm distal to
the medial epicondyle or 2.5cm distal to the lateral epicondyle. Once this is established,
intramedullary reaming can be undertaken and provisional trials evaluated for the tibia and
femur. The need for bone graft is indicated where there is inadequate support for the trial
implants by host bone 18.
The size and location of the bony deficit will dictate the type of augmentation and may
limit implant choices. Smaller defects <5mm (AORI Type I) may be addressed with cement or
cancellous bone chips

19, 20

. Type II defects of the femoral condyles or tibial plateau can

generally be addressed with metal augments attached to the implant 21. These augments come in
various sizes and are often used for distal femoral or posterior condylar bone loss (figure 1).
They may be added in a symmetric or asymmetric fashion to both the femoral and tibial
components.

[Insert Figure 1 here]

Larger contained defects involving the metaphysis of the femur or tibia can be addressed
with metallic sleeves or trabecular metal cones. Sleeves are best suited for defects involving

bone loss from medial to lateral with good anterior and posterior bone stock (figure 2). Larger
trabecular metal cones can be used for areas of more significant bone loss. Uncontained defects
of the condyles and plateau will require structural bone graft, particularly in younger patients
23

22,

. Engh has described an accepted technique utilizing femoral head allograft to reconstruct large

condylar defects with good results. The merits and drawbacks of these techniques are outlined in
table 2.

[Insert Figure 2 here]

[Insert Table 2 here]

Bony defects which compromise the collateral stability of the knee may dictate the use of
constrained or possibly hinged implants. The surgeon should keep in mind that increasing
degrees of constraint can lead to early aseptic loosening, particularly in younger and more active
patients

14

. In the revision setting, stems should also be considered for both the tibia and femur

when metal or allograft augments are used 18.
A final consideration for graft augmentation is patient age and life expectancy

18

.

Younger patients can be expected to place greater demands on implants, and future revisions
should be anticipated. The use of autograft or allograft bone is more appealing in this patient
demographic due to the potential for biologic incorporation and bone stock restoration23.

FUTURE TRENDS

Extensive research is still ongoing to identify graft options for larger bony defects in the
revision setting. Ideal properties would include substitutes which behave mechanically similar to
host bone, have a high rate of incorporation or interdigitation, allow immediate mobilization
following surgery and avoid the risk of disease transmission. Trabecular metal and tantalum
cones provide a favorable surface for osteoblast proliferation and integration, allow immediate
weight bearing and carry no risk of disease transmission. Good short term outcomes with a very
high rate of osseointegration have been reported, but future studies will be necessary to evaluate
the long term outcome of these implants 24-26. Revision of these cones may also be a major future
issue, particularly in younger patients who are expected to have one or more revisions in their
lifetime.
Research is also directed toward improving the stability of cancellous bone grafts by
mixing allograft with stiffer constituents, such as ceramic or hydroxyapatite particles

19

. The

clinical benefit of these composite grafts still has to be ascertained. Recombinant bone growth
factors such as Bone Morphogenic Protein-2 (BMP-2) and BMP-7 (also known as Osteogenic
Protein-1 or OP-1) have also been evaluated for reconstructive procedures. These proteins act to
upregulate the differentiation of pluripotent mesenchymal cells leading to enhanced bone
production. They may be used alone or in combination with bone grafts or bone substitutes

27

.

Although these proteins have shown promising preclinical results, their clinical benefit in knee
arthroplasty yet to be demonstrated in long term studies27.

CONCLUSION
Bone loss following total knee arthroplasty can be managed successfully with a wide
variety of reconstruction methods. Methods such as autograft and allograft bone should be

considered in younger patients to restore bone stock for future reconstructive procedures.
Smaller contained defects may be addressed with bone grafting, bone cement or metal augments.
Larger defects may require metaphyseal sleeves, trabecular metal cones or bulk allografts.
Intramedullary stems should be used in large defects involving the condyles or with questionable
bone stock.
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